Yuan Liu

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas

Jeffrey R. Infante, Bradley G. Somer, Joon Oh Park et al. · European Journal of Cancer · 2014 · 356 citations

Untreated Metastatic Adenocarcinoma, Oncology, Pancreatic Cancer +8

Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases

Kirtesh R. Patel, Sana Shoukat, Daniel Oliver et al. · American Journal of Clinical Oncology · 2015 · 193 citations

Outcomes and prognostic factors in modern era management of major salivary gland cancer

N. Jegadeesh, Yuan Liu, Roshan S. Prabhu et al. · Oral Oncology · 2015 · 65 citations

Prognostic Factors, Modern Era Management, Medicine +7

Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer

Alyssa N. Troeschel, Yuan Liu, Lindsay J. Collin et al. · International Journal of Epidemiology · 2019 · 53 citations · Full text

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer

David R. Gandara, Natasha B. Leighl, Jean‐Pierre Delord et al. · Journal of Thoracic Oncology · 2016 · 51 citations

Phase 1/1B, Medicine, Cancer Management +9